A mouse-CCL2-specific Spiegelmer (mNOX-E36) was shown to be active in several animal models11, 12, 13 and its human-specific counterpart NOX-E36 (emapticap pegol) has already been tested successfully in a Phase IIa study in diabetic nephropathy patients14. This evidence concerns the gene CCL2 and diabetic kidney disease.